{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T20:46:46Z","timestamp":1774644406746,"version":"3.50.1"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T00:00:00Z","timestamp":1353542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"},{"start":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T00:00:00Z","timestamp":1353542400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                        <jats:title>Introduction<\/jats:title>\n                        <jats:p>Bone is the most common site of breast cancer metastasis, and complications associated with bone metastases can lead to a significantly decreased patient quality of life. Thus, it is essential to gain a better understanding of the molecular mechanisms that underlie the emergence and growth of breast cancer skeletal metastases.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Methods<\/jats:title>\n                        <jats:p>To search for novel molecular mediators that influence breast cancer bone metastasis, we generated gene-expression profiles from laser-capture microdissected trephine biopsies of both breast cancer bone metastases and independent primary breast tumors that metastasized to bone. Bioinformatics analysis identified genes that are differentially expressed in breast cancer bone metastases compared with primary, bone-metastatic breast tumors.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Results<\/jats:title>\n                        <jats:p>ABCC5, an ATP-dependent transporter, was found to be overexpressed in breast cancer osseous metastases relative to primary breast tumors. In addition, ABCC5 was significantly upregulated in human and mouse breast cancer cell lines with high bone-metastatic potential. Stable knockdown of <jats:italic>ABCC5<\/jats:italic> substantially reduced bone metastatic burden and osteolytic bone destruction in mice. The decrease in osteolysis was further associated with diminished osteoclast numbers <jats:italic>in vivo<\/jats:italic>. Finally, conditioned media from breast cancer cells with reduced ABCC5 expression failed to induce <jats:italic>in vitro<\/jats:italic> osteoclastogenesis to the same extent as conditioned media from breast cancer cells expressing ABCC5.<\/jats:p>\n                     <\/jats:sec><jats:sec>\n                        <jats:title>Conclusions<\/jats:title>\n                        <jats:p>Our data suggest that ABCC5 functions as a mediator of breast cancer skeletal metastasis. ABCC5 expression in breast cancer cells is important for efficient osteoclast-mediated bone resorption. Hence, ABCC5 may be a potential therapeutic target for breast cancer bone metastasis.<\/jats:p>\n                     <\/jats:sec>","DOI":"10.1186\/bcr3361","type":"journal-article","created":{"date-parts":[[2012,11,23]],"date-time":"2012-11-23T01:14:17Z","timestamp":1353633257000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone"],"prefix":"10.1186","volume":"14","author":[{"given":"Anna A","family":"Mourskaia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eitan","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhifeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Tiedemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Cory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atilla","family":"Omeroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Bertos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00e9ronique","family":"Ouellet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Clemons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George L","family":"Scheffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morag","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana V","family":"Komarova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,22]]},"reference":[{"key":"3168_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK: Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011, 11: 411-425. 10.1038\/nrc3055.","journal-title":"Nat Rev Cancer"},{"key":"3168_CR2","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2010.227","volume":"7","author":"LJ Suva","year":"2011","unstructured":"Suva LJ, Washam C, Nicholas RW, Griffin RJ: Bone metastasis: mechanisms and therapeutic opportunities. Nat Rev Endocrinol. 2011, 7: 208-218. 10.1038\/nrendo.2010.227.","journal-title":"Nat Rev Endocrinol"},{"key":"3168_CR3","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10911-005-5399-8","volume":"10","author":"W Kozlow","year":"2005","unstructured":"Kozlow W, Guise TA: Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia. 2005, 10: 169-180. 10.1007\/s10911-005-5399-8.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"3168_CR4","first-page":"931","volume":"93","author":"AA Rose","year":"2006","unstructured":"Rose AA, Siegel PM: Breast cancer-derived factors facilitate osteolytic bone metastasis. Bull Cancer. 2006, 93: 931-943.","journal-title":"Bull Cancer"},{"key":"3168_CR5","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.bbrc.2004.11.070","volume":"328","author":"T Yoneda","year":"2005","unstructured":"Yoneda T, Hiraga T: Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun. 2005, 328: 679-687. 10.1016\/j.bbrc.2004.11.070.","journal-title":"Biochem Biophys Res Commun"},{"key":"3168_CR6","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.mce.2009.07.004","volume":"310","author":"S Casimiro","year":"2009","unstructured":"Casimiro S, Guise TA, Chirgwin J: The critical role of the bone microenvironment in cancer metastases. Mol Cell Endocrinol. 2009, 310: 71-81. 10.1016\/j.mce.2009.07.004.","journal-title":"Mol Cell Endocrinol"},{"key":"3168_CR7","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/bcr2781","volume":"12","author":"YC Chen","year":"2010","unstructured":"Chen YC, Sosnoski DM, Mastro AM: Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res. 2010, 12: 215-10.1186\/bcr2781.","journal-title":"Breast Cancer Res"},{"key":"3168_CR8","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1200\/JCO.2005.03.8802","volume":"24","author":"M Smid","year":"2006","unstructured":"Smid M, Wang Y, Klijn JG, Sieuwerts AM, Zhang Y, Atkins D, Martens JW, Foekens JA: Genes associated with breast cancer metastatic to bone. J Clin Oncol. 2006, 24: 2261-2267. 10.1200\/JCO.2005.03.8802.","journal-title":"J Clin Oncol"},{"key":"3168_CR9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ccr.2009.05.017","volume":"16","author":"XH Zhang","year":"2009","unstructured":"Zhang XH, Wang Q, Gerald W, Hudis CA, Norton L, Smid M, Foekens JA, Massague J: Latent bone metastasis in breast cancer tied to Src-dependent survival signals. Cancer Cell. 2009, 16: 67-78. 10.1016\/j.ccr.2009.05.017.","journal-title":"Cancer Cell"},{"key":"3168_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","volume":"3","author":"Y Kang","year":"2003","unstructured":"Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer Cell. 2003, 3: 537-549. 10.1016\/S1535-6108(03)00132-6.","journal-title":"Cancer Cell"},{"key":"3168_CR11","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.ajpath.2011.01.033","volume":"178","author":"V Ouellet","year":"2011","unstructured":"Ouellet V, Tiedemann K, Mourskaia A, Fong JE, Tran-Thanh D, Amir E, Clemons M, Perbal B, Komarova SV, Siegel PM: CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone. Am J Pathol. 2011, 178: 2377-2388. 10.1016\/j.ajpath.2011.01.033.","journal-title":"Am J Pathol"},{"key":"3168_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1158\/1541-7786.MCR-07-0119","volume":"5","author":"AA Rose","year":"2007","unstructured":"Rose AA, Pepin F, Russo C, Abou Khalil JE, Hallett M, Siegel PM: Osteoactivin promotes breast cancer metastasis to bone. Mol Cancer Res. 2007, 5: 1001-1014. 10.1158\/1541-7786.MCR-07-0119.","journal-title":"Mol Cancer Res"},{"key":"3168_CR13","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1359\/jbmr.2001.16.8.1486","volume":"16","author":"T Yoneda","year":"2001","unstructured":"Yoneda T, Williams PJ, Hiraga T, Niewolna M, Nishimura R: A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro. J Bone Miner Res. 2001, 16: 1486-1495. 10.1359\/jbmr.2001.16.8.1486.","journal-title":"J Bone Miner Res"},{"key":"3168_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1517\/14656566.2011.537260","volume":"15","author":"C Arslan","year":"2011","unstructured":"Arslan C, Sari E, Aksoy S, Altundag K: Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature. Expert Opin Ther Targets. 2011, 15: 21-30. 10.1517\/14656566.2011.537260.","journal-title":"Expert Opin Ther Targets"},{"key":"3168_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.humpath.2011.05.009","volume":"43","author":"P St Romain","year":"2012","unstructured":"St Romain P, Madan R, Tawfik OW, Damjanov I, Fan F: Organotropism and prognostic marker discordance in distant metastases of breast carcinoma: fact or fiction? A clinicopathologic analysis. Hum Pathol. 2012, 43: 398-404. 10.1016\/j.humpath.2011.05.009.","journal-title":"Hum Pathol"},{"key":"3168_CR16","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1200\/JCO.2010.33.5232","volume":"30","author":"E Amir","year":"2012","unstructured":"Amir E, Miller N, Geddie W, Freedman O, Kassam F, Simmons C, Oldfield M, Dranitsaris G, Tomlinson G, Laupacis A, Tannock IF, Clemons M: Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer. J Clin Oncol. 2012, 30: 587-592. 10.1200\/JCO.2010.33.5232.","journal-title":"J Clin Oncol"},{"key":"3168_CR17","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10549-010-1264-6","volume":"129","author":"JF Hilton","year":"2011","unstructured":"Hilton JF, Amir E, Hopkins S, Nabavi M, DiPrimio G, Sheikh A, Done SJ, Gianfelice D, Kanji F, Dent S, Barth D, Bouganim N, Al-Najjar A, Clemons M: Acquisition of metastatic tissue from patients with bone metastases from breast cancer. Breast Cancer Res Treat. 2011, 129: 761-765. 10.1007\/s10549-010-1264-6.","journal-title":"Breast Cancer Res Treat"},{"key":"3168_CR18","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5: R80-10.1186\/gb-2004-5-10-r80.","journal-title":"Genome Biol"},{"key":"3168_CR19","unstructured":"The National Center for Biotechnology Information. [http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?token=njwzhwsagooekps&acc=GSE39494]"},{"key":"3168_CR20","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1093\/emboj\/18.8.2149","volume":"18","author":"PM Siegel","year":"1999","unstructured":"Siegel PM, Ryan ED, Cardiff RD, Muller WJ: Elevated expression of activated forms of Neu\/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J. 1999, 18: 2149-2164. 10.1093\/emboj\/18.8.2149.","journal-title":"EMBO J"},{"key":"3168_CR21","unstructured":"RNAi central. [http:\/\/katahdin.cshl.org\/siRNA\/RNAi.cgi?type=shRNA]"},{"key":"3168_CR22","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/ng1651","volume":"37","author":"RA Dickins","year":"2005","unstructured":"Dickins RA, Hemann MT, Zilfou JT, Simpson DR, Ibarra I, Hannon GJ, Lowe SW: Probing tumor phenotypes using stable and regulated synthetic microRNA precursors. Nat Genet. 2005, 37: 1289-1295.","journal-title":"Nat Genet"},{"key":"3168_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, Ponomarev V, Gerald WL, Blasberg R, Massague J: Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005, 115: 44-55.","journal-title":"J Clin Invest"},{"key":"3168_CR24","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1101\/sqb.2005.70.018","volume":"70","author":"GP Gupta","year":"2005","unstructured":"Gupta GP, Minn AJ, Kang Y, Siegel PM, Serganova I, Cordon-Cardo C, Olshen AB, Gerald WL, Massague J: Identifying site-specific metastasis genes and functions. Cold Spring Harb Symp Quant Biol. 2005, 70: 149-158. 10.1101\/sqb.2005.70.018.","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"3168_CR25","first-page":"1399","volume":"52","author":"CJ Aslakson","year":"1992","unstructured":"Aslakson CJ, Miller FR: Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res. 1992, 52: 1399-1405.","journal-title":"Cancer Res"},{"key":"3168_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1242\/jcs.031534","volume":"122","author":"S Armstrong","year":"2009","unstructured":"Armstrong S, Pereverzev A, Dixon SJ, Sims SM: Activation of P2X7 receptors causes isoform-specific translocation of protein kinase C in osteoclasts. J Cell Sci. 2009, 122: 136-144. 10.1242\/jcs.031534.","journal-title":"J Cell Sci"},{"key":"3168_CR27","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1038\/onc.2008.454","volume":"28","author":"AA Mourskaia","year":"2009","unstructured":"Mourskaia AA, Dong Z, Ng S, Banville M, Zwaagstra JC, O'Connor-McCourt MD, Siegel PM: Transforming growth factor-beta1 is the predominant isoform required for breast cancer cell outgrowth in bone. Oncogene. 2009, 28: 1005-1015. 10.1038\/onc.2008.454.","journal-title":"Oncogene"},{"key":"3168_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1186\/1471-2407-11-443","volume":"11","author":"M Labelle-Cote","year":"2011","unstructured":"Labelle-Cote M, Dusseault J, Ismail S, Picard-Cloutier A, Siegel PM, Larose L: Nck2 promotes human melanoma cell proliferation, migration and invasion in vitro and primary melanoma-derived tumor growth in vivo. BMC Cancer. 2011, 11: 443-10.1186\/1471-2407-11-443.","journal-title":"BMC Cancer"},{"key":"3168_CR29","first-page":"3247","volume":"123","author":"AJ Xu","year":"2010","unstructured":"Xu AJ, Xia XH, Du ST, Gu JC: Clinical significance of PHPT1 protein expression in lung cancer. Chin Med J (Engl). 2010, 123: 3247-3251.","journal-title":"Chin Med J (Engl)"},{"key":"3168_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/1476-4598-10-75","volume":"10","author":"BV McConnell","year":"2011","unstructured":"McConnell BV, Koto K, Gutierrez-Hartmann A: Nuclear and cytoplasmic LIMK1 enhances human breast cancer progression. Mol Cancer. 2011, 10: 75-10.1186\/1476-4598-10-75.","journal-title":"Mol Cancer"},{"key":"3168_CR31","doi-asserted-by":"publisher","first-page":"21680","DOI":"10.1074\/jbc.M500752200","volume":"280","author":"DP LaLonde","year":"2005","unstructured":"LaLonde DP, Brown MC, Bouverat BP, Turner CE: Actopaxin interacts with TESK1 to regulate cell spreading on fibronectin. J Biol Chem. 2005, 280: 21680-21688. 10.1074\/jbc.M500752200.","journal-title":"J Biol Chem"},{"key":"3168_CR32","first-page":"213","volume":"117","author":"CR Liu","year":"2004","unstructured":"Liu CR, Ma CS, Ning JY, You JF, Liao SL, Zheng J: Differential thymosin beta 10 expression levels and actin filament organization in tumor cell lines with different metastatic potential. Chin Med J (Engl). 2004, 117: 213-218.","journal-title":"Chin Med J (Engl)"},{"key":"3168_CR33","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1349-7006.2007.00434.x","volume":"98","author":"S Mochizuki","year":"2007","unstructured":"Mochizuki S, Okada Y: ADAMs in cancer cell proliferation and progression. Cancer Sci. 2007, 98: 621-628. 10.1111\/j.1349-7006.2007.00434.x.","journal-title":"Cancer Sci"},{"key":"3168_CR34","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1741-7015-9-95","volume":"9","author":"F Mannello","year":"2011","unstructured":"Mannello F: What does matrix metalloproteinase-1 expression in patients with breast cancer really tell us?. BMC Med. 2011, 9: 95-10.1186\/1741-7015-9-95.","journal-title":"BMC Med"},{"key":"3168_CR35","doi-asserted-by":"publisher","first-page":"8119","DOI":"10.4049\/jimmunol.0901925","volume":"183","author":"M Steenport","year":"2009","unstructured":"Steenport M, Khan KM, Du B, Barnhard SE, Dannenberg AJ, Falcone DJ: Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-alpha and cyclooxygenase-2. J Immunol. 2009, 183: 8119-8127. 10.4049\/jimmunol.0901925.","journal-title":"J Immunol"},{"key":"3168_CR36","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.mvr.2008.01.001","volume":"76","author":"AR Albig","year":"2008","unstructured":"Albig AR, Becenti DJ, Roy TG, Schiemann WP: Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc Res. 2008, 76: 7-14. 10.1016\/j.mvr.2008.01.001.","journal-title":"Microvasc Res"},{"key":"3168_CR37","doi-asserted-by":"publisher","first-page":"4621","DOI":"10.1158\/0008-5472.CAN-08-3402","volume":"69","author":"A Courtwright","year":"2009","unstructured":"Courtwright A, Siamakpour-Reihani S, Arbiser JL, Banet N, Hilliard E, Fried L, Livasy C, Ketelsen D, Nepal DB, Perou CM, Patterson C, Klauber-Demore N: Secreted frizzle-related protein 2 stimulates angiogenesis via a calcineurin\/NFAT signaling pathway. Cancer Res. 2009, 69: 4621-4628. 10.1158\/0008-5472.CAN-08-3402.","journal-title":"Cancer Res"},{"key":"3168_CR38","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ccr.2011.10.016","volume":"20","author":"EM Amin","year":"2011","unstructured":"Amin EM, Oltean S, Hua J, Gammons MV, Hamdollah-Zadeh M, Welsh GI, Cheung MK, Ni L, Kase S, Rennel ES, Symonds KE, Nowak DG, Royer-Pokora B, Saleem MA, Hagiwara M, Schumacher VA, Harper SJ, Hinton DR, Bates DO, Ladomery MR: WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing. Cancer Cell. 2011, 20: 768-780. 10.1016\/j.ccr.2011.10.016.","journal-title":"Cancer Cell"},{"issue":"Suppl 1","key":"3168_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1634\/theoncologist.5-suppl_1-3","volume":"5","author":"G McMahon","year":"2000","unstructured":"McMahon G: VEGF receptor signaling in tumor angiogenesis. Oncologist. 2000, 5 (Suppl 1): 3-10.","journal-title":"Oncologist"},{"key":"3168_CR40","doi-asserted-by":"publisher","first-page":"4456","DOI":"10.1038\/onc.2009.292","volume":"28","author":"R Shao","year":"2009","unstructured":"Shao R, Hamel K, Petersen L, Cao QJ, Arenas RB, Bigelow C, Bentley B, Yan W: YKL-40, a secreted glycoprotein, promotes tumor angiogenesis. Oncogene. 2009, 28: 4456-4468. 10.1038\/onc.2009.292.","journal-title":"Oncogene"},{"key":"3168_CR41","doi-asserted-by":"publisher","first-page":"e7955","DOI":"10.1371\/journal.pone.0007955","volume":"4","author":"AS Chan","year":"2009","unstructured":"Chan AS, Jensen KK, Skokos D, Doty S, Lederman HK, Kaplan RN, Rafii S, Rivella S, Lyden D: Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis. PLoS One. 2009, 4: e7955-10.1371\/journal.pone.0007955.","journal-title":"PLoS One"},{"key":"3168_CR42","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1365-2141.1999.01311.x","volume":"105","author":"S Nakayama","year":"1999","unstructured":"Nakayama S, Iida K, Tsuzuki T, Iwashita T, Murakami H, Asai N, Iwata Y, Ichihara M, Ito S, Kawai K, Asai M, Kurokawa K, Takahashi M: Implication of expression of GDNF\/Ret signalling components in differentiation of bone marrow haemopoietic cells. Br J Haematol. 1999, 105: 50-57. 10.1111\/j.1365-2141.1999.01311.x.","journal-title":"Br J Haematol"},{"key":"3168_CR43","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1182\/blood-2008-09-179788","volume":"114","author":"HC Suh","year":"2009","unstructured":"Suh HC, Ji M, Gooya J, Lee M, Klarmann KD, Keller JR: Cell-nonautonomous function of Id1 in the hematopoietic progenitor cell niche. Blood. 2009, 114: 1186-1195. 10.1182\/blood-2008-09-179788.","journal-title":"Blood"},{"key":"3168_CR44","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.lfs.2010.02.012","volume":"86","author":"XW Ding","year":"2010","unstructured":"Ding XW, Wu JH, Jiang CP: ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy. Life Sci. 2010, 86: 631-637. 10.1016\/j.lfs.2010.02.012.","journal-title":"Life Sci"},{"key":"3168_CR45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10555-006-9036-9","volume":"25","author":"RN Kaplan","year":"2006","unstructured":"Kaplan RN, Psaila B, Lyden D: Bone marrow cells in the \"pre-metastatic niche\": within bone and beyond. Cancer Metastasis Rev. 2006, 25: 521-529.","journal-title":"Cancer Metastasis Rev"},{"key":"3168_CR46","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1172\/JCI43414","volume":"121","author":"Y Shiozawa","year":"2011","unstructured":"Shiozawa Y, Pedersen EA, Havens AM, Jung Y, Mishra A, Joseph J, Kim JK, Patel LR, Ying C, Ziegler AM, Pienta MJ, Song J, Wang J, Loberg RD, Krebsbach PH, Pienta KJ, Taichman RS: Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. J Clin Invest. 2011, 121: 1298-1312. 10.1172\/JCI43414.","journal-title":"J Clin Invest"},{"key":"3168_CR47","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1038\/cdd.2011.17","volume":"18","author":"PN Kelly","year":"2011","unstructured":"Kelly PN, Strasser A: The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy. Cell Death Differ. 2011, 18: 1414-1424. 10.1038\/cdd.2011.17.","journal-title":"Cell Death Differ"},{"key":"3168_CR48","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1016\/j.biocel.2010.07.014","volume":"42","author":"MA Kutuzov","year":"2010","unstructured":"Kutuzov MA, Bennett N, Andreeva AV: Protein phosphatase with EF-hand domains 2 (PPEF2) is a potent negative regulator of apoptosis signal regulating kinase-1 (ASK1). Int J Biochem Cell Biol. 2010, 42: 1816-1822. 10.1016\/j.biocel.2010.07.014.","journal-title":"Int J Biochem Cell Biol"},{"key":"3168_CR49","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/cdd.2011.121","volume":"19","author":"T Kaufmann","year":"2012","unstructured":"Kaufmann T, Strasser A, Jost PJ: Fas death receptor signalling: roles of Bid and XIAP. Cell Death Differ. 2012, 19: 42-50. 10.1038\/cdd.2011.121.","journal-title":"Cell Death Differ"},{"key":"3168_CR50","doi-asserted-by":"publisher","first-page":"6447","DOI":"10.1016\/j.febslet.2006.10.067","volume":"580","author":"A Szigeti","year":"2006","unstructured":"Szigeti A, Bellyei S, Gasz B, Boronkai A, Hocsak E, Minik O, Bognar Z, Varbiro G, Sumegi B, Gallyas F: Induction of necrotic cell death and mitochondrial permeabilization by heme binding protein 2\/SOUL. FEBS Lett. 2006, 580: 6447-6454. 10.1016\/j.febslet.2006.10.067.","journal-title":"FEBS Lett"},{"key":"3168_CR51","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1128\/MCB.01273-08","volume":"29","author":"N Micali","year":"2009","unstructured":"Micali N, Ferrai C, Fernandez-Diaz LC, Blasi F, Crippa MP: Prep1 directly regulates the intrinsic apoptotic pathway by controlling Bcl-XL levels. Mol Cell Biol. 2009, 29: 1143-1151. 10.1128\/MCB.01273-08.","journal-title":"Mol Cell Biol"},{"key":"3168_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1084\/jem.20111117","volume":"209","author":"R Schulz","year":"2012","unstructured":"Schulz R, Marchenko ND, Holembowski L, Fingerle-Rowson G, Pesic M, Zender L, Dobbelstein M, Moll UM: Inhibiting the HSP90 chaperone destabilizes macrophage migration inhibitory factor and thereby inhibits breast tumor progression. J Exp Med. 2012, 209: 275-289. 10.1084\/jem.20111117.","journal-title":"J Exp Med"},{"key":"3168_CR53","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.1021\/pr900430n","volume":"8","author":"S Lim","year":"2009","unstructured":"Lim S, Choong LY, Kuan CP, Yunhao C, Lim YP: Regulation of macrophage inhibitory factor (MIF) by epidermal growth factor receptor (EGFR) in the MCF10AT model of breast cancer progression. J Proteome Res. 2009, 8: 4062-4076. 10.1021\/pr900430n.","journal-title":"J Proteome Res"},{"key":"3168_CR54","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.canlet.2007.11.028","volume":"261","author":"X Xu","year":"2008","unstructured":"Xu X, Wang B, Ye C, Yao C, Lin Y, Huang X, Zhang Y, Wang S: Overexpression of macrophage migration inhibitory factor induces angiogenesis in human breast cancer. Cancer Lett. 2008, 261: 147-157. 10.1016\/j.canlet.2007.11.028.","journal-title":"Cancer Lett"},{"key":"3168_CR55","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1038\/sj.onc.1210318","volume":"26","author":"H Lue","year":"2007","unstructured":"Lue H, Thiele M, Franz J, Dahl E, Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Luscher B, Bernhagen J: Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5\/JAB1 in the control of autocrine MIF activity. Oncogene. 2007, 26: 5046-5059. 10.1038\/sj.onc.1210318.","journal-title":"Oncogene"},{"key":"3168_CR56","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1349-7006.2002.tb01269.x","volume":"93","author":"H Bando","year":"2002","unstructured":"Bando H, Matsumoto G, Bando M, Muta M, Ogawa T, Funata N, Nishihira J, Koike M, Toi M: Expression of macrophage migration inhibitory factor in human breast cancer: association with nodal spread. Jpn J Cancer Res. 2002, 93: 389-396. 10.1111\/j.1349-7006.2002.tb01269.x.","journal-title":"Jpn J Cancer Res"},{"key":"3168_CR57","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1471-2407-9-230","volume":"9","author":"E Verjans","year":"2009","unstructured":"Verjans E, Noetzel E, Bektas N, Schutz AK, Lue H, Lennartz B, Hartmann A, Dahl E, Bernhagen J: Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer. BMC Cancer. 2009, 9: 230-10.1186\/1471-2407-9-230.","journal-title":"BMC Cancer"},{"key":"3168_CR58","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/j.bone.2009.06.028","volume":"45","author":"C Jacquin","year":"2009","unstructured":"Jacquin C, Koczon-Jaremko B, Aguila HL, Leng L, Bucala R, Kuchel GA, Lee SK: Macrophage migration inhibitory factor inhibits osteoclastogenesis. Bone. 2009, 45: 640-649. 10.1016\/j.bone.2009.06.028.","journal-title":"Bone"},{"key":"3168_CR59","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.bcp.2012.01.002","volume":"83","author":"K Natarajan","year":"2012","unstructured":"Natarajan K, Xie Y, Baer MR, Ross DD: Role of breast cancer resistance protein (BCRP\/ABCG2) in cancer drug resistance. Biochem Pharmacol. 2012, 83: 1084-1103. 10.1016\/j.bcp.2012.01.002.","journal-title":"Biochem Pharmacol"},{"key":"3168_CR60","unstructured":"Human ABC-Transporters. [http:\/\/nutrigene.4t.com\/humanabc.htm]"},{"key":"3168_CR61","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/1479-7364-3-3-281","volume":"3","author":"V Vasiliou","year":"2009","unstructured":"Vasiliou V, Vasiliou K, Nebert DW: Human ATP-binding cassette (ABC) transporter family. Hum Genomics. 2009, 3: 281-290.","journal-title":"Hum Genomics"},{"key":"3168_CR62","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1017\/S002202990800335X","volume":"75","author":"C Farke","year":"2008","unstructured":"Farke C, Meyer HH, Bruckmaier RM, Albrecht C: Differential expression of ABC transporters and their regulatory genes during lactation and dry period in bovine mammary tissue. J Dairy Res. 2008, 75: 406-414. 10.1017\/S002202990800335X.","journal-title":"J Dairy Res"},{"key":"3168_CR63","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1128\/MCB.01621-06","volume":"27","author":"AE van Herwaarden","year":"2007","unstructured":"van Herwaarden AE, Wagenaar E, Merino G, Jonker JW, Rosing H, Beijnen JH, Schinkel AH: Multidrug transporter ABCG2\/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk. Mol Cell Biol. 2007, 27: 1247-1253. 10.1128\/MCB.01621-06.","journal-title":"Mol Cell Biol"},{"key":"3168_CR64","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10911-009-9109-9","volume":"14","author":"M Dean","year":"2009","unstructured":"Dean M: ABC transporters, drug resistance, and cancer stem cells. J Mammary Gland Biol Neoplasia. 2009, 14: 3-9. 10.1007\/s10911-009-9109-9.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"3168_CR65","doi-asserted-by":"publisher","first-page":"30069","DOI":"10.1074\/jbc.M005463200","volume":"275","author":"G Jedlitschky","year":"2000","unstructured":"Jedlitschky G, Burchell B, Keppler D: The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides. J Biol Chem. 2000, 275: 30069-30074.","journal-title":"J Biol Chem"},{"key":"3168_CR66","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1158\/1535-7163.MCT-04-0291","volume":"4","author":"S Pratt","year":"2005","unstructured":"Pratt S, Shepard RL, Kandasamy RA, Johnston PA, Perry W, Dantzig AH: The multidrug resistance protein 5 (ABCC5) confers resistance to 5-fluorouracil and transports its monophosphorylated metabolites. Mol Cancer Ther. 2005, 4: 855-863. 10.1158\/1535-7163.MCT-04-0291.","journal-title":"Mol Cancer Ther"},{"key":"3168_CR67","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10549-006-9175-2","volume":"99","author":"S Park","year":"2006","unstructured":"Park S, Shimizu C, Shimoyama T, Takeda M, Ando M, Kohno T, Katsumata N, Kang YK, Nishio K, Fujiwara Y: Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res Treat. 2006, 99: 9-17. 10.1007\/s10549-006-9175-2.","journal-title":"Breast Cancer Res Treat"},{"key":"3168_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2184.2012.00819.x","volume":"45","author":"R Saravani","year":"2012","unstructured":"Saravani R, Karami-Tehrani F, Hashemi M, Aghaei M, Edalat R: Inhibition of phosphodiestrase 9 induces cGMP accumulation and apoptosis in human breast cancer cell lines, MCF-7 and MDA-MB-468. Cell Prolif. 2012, 45: 199-206. 10.1111\/j.1365-2184.2012.00819.x.","journal-title":"Cell Prolif"},{"key":"3168_CR69","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.1111\/j.1742-4658.2011.08260.x","volume":"278","author":"F Fallahian","year":"2011","unstructured":"Fallahian F, Karami-Tehrani F, Salami S, Aghaei M: Cyclic GMP induced apoptosis via protein kinase G in oestrogen receptor-positive and -negative breast cancer cell lines. FEBS J. 2011, 278: 3360-3369. 10.1111\/j.1742-4658.2011.08260.x.","journal-title":"FEBS J"},{"key":"3168_CR70","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.niox.2009.11.007","volume":"22","author":"K Mujoo","year":"2010","unstructured":"Mujoo K, Sharin VG, Martin E, Choi BK, Sloan C, Nikonoff LE, Kots AY, Murad F: Role of soluble guanylyl cyclase-cyclic GMP signaling in tumor cell proliferation. Nitric Oxide. 2010, 22: 43-50. 10.1016\/j.niox.2009.11.007.","journal-title":"Nitric Oxide"},{"key":"3168_CR71","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ydbio.2008.04.031","volume":"319","author":"CC Teixeira","year":"2008","unstructured":"Teixeira CC, Agoston H, Beier F: Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification. Dev Biol. 2008, 319: 171-178. 10.1016\/j.ydbio.2008.04.031.","journal-title":"Dev Biol"},{"key":"3168_CR72","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10585-012-9464-6","volume":"29","author":"S Babykutty","year":"2012","unstructured":"Babykutty S, Suboj P, Srinivas P, Nair AS, Chandramohan K, Gopala S: Insidious role of nitric oxide in migration\/invasion of colon cancer cells by upregulating MMP-2\/9 via activation of cGMP-PKG-ERK signaling pathways. Clin Exp Metast. 2012, 29: 471-492. 10.1007\/s10585-012-9464-6.","journal-title":"Clin Exp Metast"},{"key":"3168_CR73","doi-asserted-by":"publisher","first-page":"16898","DOI":"10.1073\/pnas.0702761104","volume":"104","author":"LA Ridnour","year":"2007","unstructured":"Ridnour LA, Windhausen AN, Isenberg JS, Yeung N, Thomas DD, Vitek MP, Roberts DD, Wink DA: Nitric oxide regulates matrix metalloproteinase-9 activity by guanylyl-cyclase-dependent and -independent pathways. Proc Natl Acad Sci USA. 2007, 104: 16898-16903. 10.1073\/pnas.0702761104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3168_CR74","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1128\/MCB.23.14.4901-4916.2003","volume":"23","author":"S Akool el","year":"2003","unstructured":"Akool el S, Kleinert H, Hamada FM, Abdelwahab MH, Forstermann U, Pfeilschifter J, Eberhardt W: Nitric oxide increases the decay of matrix metalloproteinase 9 mRNA by inhibiting the expression of mRNA-stabilizing factor HuR. Mol Cell Biol. 2003, 23: 4901-4916. 10.1128\/MCB.23.14.4901-4916.2003.","journal-title":"Mol Cell Biol"},{"key":"3168_CR75","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.1158\/0008-5472.CAN-09-0067","volume":"69","author":"WJ Lubbe","year":"2009","unstructured":"Lubbe WJ, Zuzga DS, Zhou Z, Fu W, Pelta-Heller J, Muschel RJ, Waldman SA, Pitari GM: Guanylyl cyclase C prevents colon cancer metastasis by regulating tumor epithelial cell matrix metalloproteinase-9. Cancer Res. 2009, 69: 3529-3536. 10.1158\/0008-5472.CAN-09-0067.","journal-title":"Cancer Res"},{"key":"3168_CR76","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1002\/(SICI)1097-4644(19990615)73:4<478::AID-JCB6>3.0.CO;2-T","volume":"73","author":"SS Dong","year":"1999","unstructured":"Dong SS, Williams JP, Jordan SE, Cornwell T, Blair HC: Nitric oxide regulation of cGMP production in osteoclasts. J Cell Biochem. 1999, 73: 478-487. 10.1002\/(SICI)1097-4644(19990615)73:4<478::AID-JCB6>3.0.CO;2-T.","journal-title":"J Cell Biochem"},{"key":"3168_CR77","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1002\/jcb.20009","volume":"91","author":"BB Yaroslavskiy","year":"2004","unstructured":"Yaroslavskiy BB, Li Y, Ferguson DJ, Kalla SE, Oakley JI, Blair HC: Autocrine and paracrine nitric oxide regulate attachment of human osteoclasts. J Cell Biochem. 2004, 91: 962-972. 10.1002\/jcb.20009.","journal-title":"J Cell Biochem"},{"key":"3168_CR78","doi-asserted-by":"publisher","first-page":"5479","DOI":"10.1242\/jcs.02655","volume":"118","author":"BB Yaroslavskiy","year":"2005","unstructured":"Yaroslavskiy BB, Zhang Y, Kalla SE, Garcia Palacios V, Sharrow AC, Li Y, Zaidi M, Wu C, Blair HC: NO-dependent osteoclast motility: reliance on cGMP-dependent protein kinase I and VASP. J Cell Sci. 2005, 118: 5479-5487. 10.1242\/jcs.02655.","journal-title":"J Cell Sci"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/bcr3361\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/bcr3361.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T10:49:30Z","timestamp":1728384570000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/bcr3361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,22]]},"references-count":78,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2012,12]]}},"alternative-id":["3168"],"URL":"https:\/\/doi.org\/10.1186\/bcr3361","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,22]]},"assertion":[{"value":"14 July 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"R149"}}